Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Birmingham Post
Birmingham Post
Business
Lauren Phillips

Pharma firm creating up to 40 new jobs in Tredegar

A Tredegar-based pharmaceutical firm is creating up to 40 new jobs as part of multi-million pound expansion plans as it looks to meet market demand.

PCI Pharma Services, which provides drug development and manufacturing services for the pharmaceutical industry, plans to open two new facilities as part of expansion plans at its site in Tafarnaubach Industrial Estate, in Blaenau Gwent.

The expansion is expected to create up to 40 new jobs in the first year, with potential to increase its workforce going forward as the facilities scale up to allow the business to enhance its drug manufacturing operations.

Read more: The new £50m equity fund for the Cardiff Capital Region

PCI Pharma plans to recruit the majority of the new staff locally.

The firm currently employs 500 people in Tredegar, but this increases to over 900 employees to include its sites in Bridgend and Hay-on-Wye.

The firm also has 30 sites across seven countries - Australia, Canada, USA, Ireland, Germany, Spain and Wales - and more than 4,300 employees across the business.

In 2020, the firm had its plans for a £9m expansion creating up to 100 new jobs approved by Blaenau Gwent Council’s planning committee.

General manager Rebecca Coutts said: “PCI has been manufacturing in Tredegar for nearly 40 years and this investment reinforces our commitment to this area.

“The expansion of the Tredegar site provides us with another opportunity to recruit locally which we hope will have an additional benefit to other businesses and the wider community.

“We are proud to be one of the leading employers in the area and the role this new facility will play in our continued growth and success.

Chief executive Salim Haffar said: “We’re excited to announce the latest expansion in Tredegar that will address the continued growth and urgent need for specialty global manufacturing services across the oncology arena.

“As the market expands for potent therapies and highly complex, concentrated formulations that can present unique challenges to manufacturing and packaging, we’re proud to be one of the few providers with the global capabilities to manage this specialty at scale”.

Read more:

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.